You are here:Home-Chemical Inhibitors & Agonists-GPCR-Orexin Receptor-Lemborexant
Lemborexant

Chemical Structure : Lemborexant

CAS No.: 1369764-02-2

Lemborexant (E-2006;E2006)

Catalog No.: PC-45062Not For Human Use, Lab Use Only.

An orally active, potent, selective, dual Orexin receptor OX1/2 antagonist with binding Ki of 6/3 nM, respectively.

Packing Price Stock Quantity
10 mg $400 In stock
50 mg $1200 In stock
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

An orally active, potent, selective, dual Orexin receptor OX1/2 antagonist with binding Ki of 6/3 nM, respectively; exhibits an overall improvement in properties such as the TDI of CYP3A and aqueous solubility, high OXRs antagonist activity and sufficient brain penetration; demonstrates high efficacy in preclinical sleep experiments.

Sleep Disorder

Phase 3 Clinical

Physicochemical Properties

M.Wt 410.4166
Formula C22H20F2N4O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: ≥ 30 mg/mL

Chemical Name/SMILES

Cyclopropanecarboxamide, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-

References

1. Yoshida Y, et al. J Med Chem. 2015 Jun 11;58(11):4648-64.

2. Beuckmann CT, et al. J Pharmacol Exp Ther. 2017 Aug;362(2):287-295.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: